Related Experiment Video
Updated: Aug 5, 2026

Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
Mitochondria-Targeting Metal Complexes: Design Principles, Mechanisms of Action, and Translational Perspectives
Donatella Coradduzza1, Giacomo Senzacqua2, Rosita Cappai2
1Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Mitochondria-targeting metal complexes (MTMCs) offer a distinct approach to cancer therapy by exploiting mitochondrial vulnerabilities. Rigorous analytical and pharmacokinetic studies are crucial for advancing MTMC clinical translation.
Area of Science:
- Metallopharmaceuticals
- Mitochondrial Biology
- Cancer Therapeutics
Background:
- Mitochondria-targeting metal complexes (MTMCs) represent a novel class of metallopharmaceuticals distinct from traditional platinum drugs.
- MTMCs leverage unique mitochondrial features like membrane potential, reactive oxygen species (ROS), and limited DNA repair capacity.
Purpose of the Study:
- To systematically review and analyze the latest trends in MTMC drug design, mechanisms of action, and analytical techniques.
- To critically evaluate translational barriers and clinical failures in MTMC development.
- To establish a clear hierarchy for evidence of mitochondrial localization.
Main Methods:
- Systematic literature search of PubMed, Web of Science, Scopus, and Google Scholar (2016-2026).
- Inclusion criteria focused on subcellular localization evidence and bioenergetic endpoints.
- Analysis of studies involving various metal complexes (Pt, Ru, Au, Ir, Os, Re, V) and metal-organic frameworks.
Main Results:
- 147 studies identified, detailing mechanisms targeting electron transport chain complexes, ROS production, mitochondrial membrane permeabilization, and mitochondrial DNA (mtDNA) damage.
- Recurrent finding of multi-modal cell death (apoptosis, ferroptosis, necroptosis, autophagy).
- Highlighted limitations of relying solely on membrane potential for targeting and the need for speciation-aware pharmacokinetics.
Conclusions:
- Translational success of MTMCs hinges on analytical rigor, speciation-aware pharmacokinetics, organelle-level safety monitoring, and biomarker-guided patient selection.
- Distinguishing true MTMCs from merely mitochondria-localizing agents requires robust evidence.
- Future progress depends on analytical advancements rather than solely new chemotypes.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
The Inner Mitochondrial Membrane

